Purpose
To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level.
Methods
National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease.
Results
55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451–2.949,
p
<0.001; OR 1.352, CI 1.227–1.489,
p
<0.001); OR 1.211, CI 1.086–1.352,
p
<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12–1.344,
p
<0.001; OR 1.363, CI 1.243–1.495,
p
<0.001; OR 1.418, CI 1.134–1.774; OR 1.388, CI 1.27–1.518,
p
<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors.
Conclusion
Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts.